Freedom to Operate for MedTech Startups: When to Run an FTO Search and How to Do It Right

2026-07-14 · Caduvo Team

A freedom to operate analysis is a legal must for medtech startups. Learn what an FTO search covers, when to run one, typical costs, and how to design around blocking patents.

You’ve just received a letter from a competitor’s law firm. The subject line isn’t a press release or a partnership offer — it’s a notice of patent infringement. Your device is already on the market, and now you’re facing a legal battle that could cost more than your entire seed round. This scenario is avoidable. A freedom to operate analysis, performed early and revisited at key milestones, lets you launch with confidence that you’re not walking into someone else’s IP territory.

What a Freedom to Operate Analysis Is (and Isn’t)

A freedom to operate analysis (FTO) is a legal opinion that assesses whether your medical device product infringes any in-force patent claims in the countries where you plan to manufacture, sell, or use it. It’s not a patentability search. You’re not looking for prior art to prove your invention is new. You’re checking whether someone else’s existing rights could block your commercial path.

For a medtech startup, that distinction matters. You can receive a patent on your device and still be unable to sell it if a broader, earlier patent covering the same core technology remains in force. The FTO analysis answers the question you actually care about: Can I bring this product to market without getting sued?

FTO vs. Patentability: Two Different Questions

Patentability asks: “Can I get a patent on my invention?” The answer depends on novelty, non-obviousness, and a handful of other statutory requirements. It’s a conversation you have with the patent office.

FTO asks: “Can I sell my product without infringing someone else’s patent?” This is a conversation with the patent landscape. The two analyses are complementary, but they look in opposite directions. Patentability focuses on what you can own. FTO focuses on what others already own.

A medtech startup might file a patent application on a novel catheter handle design. The patentability search clears the way for a strong patent. But an FTO search might uncover an existing patent on the internal locking mechanism that the handle relies on — a patent the startup doesn’t own. That’s a blocking patent. The startup’s own patent doesn’t give it the right to practice the locking mechanism; it only gives it the right to exclude others from the same handle design. This is why a freedom to operate analysis is a separate step in your IP strategy.

What an FTO Search Actually Covers

An FTO search digs into the full text of patent claims, not just abstracts or titles. The claims define the legal boundaries of what the patent owner can enforce. A patent’s abstract might describe a surgical stapler, but the claims might be narrow enough to leave room for your design. An FTO search must analyze each independent claim and compare it to your product’s features.

Here’s what a thorough freedom to operate search includes:

Review of active patents and published applications in every jurisdiction where you plan to sell, manufacture, or use the device.
Claim-by-claim analysis against your product’s specifications, often using claim charts that map each claim element to your device.
Assessment of patent validity, expiration dates, and maintenance fee status.
Consideration of pending applications that could later issue as patents with claims you haven’t seen yet.

A quick keyword search on Google Patents is not an FTO search. It misses non-English patents, expired patents that might have been revived, and claims that are drafted in a way that doesn’t match your terminology. The typical FTO search relies on professional patent databases, classification code searches, and attorney review.

When to Run Your First FTO Analysis

Timing can make or break a medtech startup’s budget. Run an FTO too early, and you might waste money on a design that will change. Run it too late, and you’ve already invested in tooling, regulatory submissions, and clinical studies for a product that infringes.

A practical timeline looks like this:

Concept stage: Perform a landscape search — a lighter, broader review to identify potential blocking patents and major competitors’ IP. This costs less than a full FTO and can guide your design direction.
Design freeze: Conduct a formal freedom to operate analysis. At this point, your product specifications are solid enough to compare against claims. The attorney’s opinion will tell you whether you can proceed or need to design around.
Pre-submission: Before you file a 510(k) or PMA, update the FTO. New patents may have issued, and the claims landscape can shift.
Pre-launch: A final check before you start selling. If you’ve been in development for two years, a lot can change.

For a medtech startup, skipping the FTO until after FDA clearance is a common mistake. FDA clearance is not a patent license. It doesn’t protect you from infringement suits. Budget for both paths — regulatory and IP — in parallel.

What to Do When You Find a Blocking Patent (Design-Arounds and More)

A blocking patent doesn’t have to kill your product. Here are the options a medtech startup can pursue:

Design around the claims: Modify your device so it no longer falls within the literal scope of the independent claims. Even a small change — a different material, an alternative mechanism — can avoid infringement if the claims are written narrowly.
License the patent: Approach the patent holder and negotiate a royalty-bearing license. This can be expensive but turns a competitor into a partner and removes the legal risk.
Challenge validity: If you find prior art that the patent examiner missed, you can file a post-grant review or seek a declaratory judgment of invalidity. This is a high-stakes route, but it can clear the field entirely.
Pivot the market: If the patent is only in force in the U.S., consider launching first in Europe or another jurisdiction where you’re clear. Use that revenue to fund a wider launch or a license.
Do nothing: This is the riskiest gamble. If the patent owner doesn’t notice you, you might get away with it — but if they do, the median cost of defending a patent infringement case through trial tops $2 million for cases with less than $25 million at risk.

A freedom to operate analysis doesn’t just flag problems; it gives you a decision framework. You can weigh the cost of a design change against the cost of licensing or litigation, and make a business call.

Key Takeaways

A freedom to operate analysis is a legal assessment of whether your device infringes existing patent claims. It’s separate from patentability.
An FTO search is built on claim analysis, not abstracts. Budget for a professional search and attorney opinion.
Run a landscape search early, then a formal FTO at design freeze, and update it before regulatory submission and launch.
If you find a blocking patent, you have options: design around, license, challenge validity, or pivot.
FDA clearance is not a patent license. Plan your IP clearance alongside your regulatory strategy.

Caduvo’s platform can’t replace a patent attorney, but it can help you map the regulatory and reimbursement side of your market access strategy, so you’re not caught off guard by coding or coverage gaps while you’re clearing your FTO path.